For families facing a prenatal diagnosis of clubfoot, our CFDT and orthopaedic experts meet with families to discuss findings, postnatal management, treatment options, and long-term prognosis.

Research published by CHOP confirms the effectiveness of low-dose fetal CT in detecting prenatal osseous abnormalities, which allows increased diagnosis confidence and more precise parental counseling.

Cindy Christian, MD, Alumni Editor, highlights upcoming events and the new Alumni Organization website, and provides a recap from Dr. Prabha Viswanathan, a CHOP alumnus.

Charles Phillips, MD, a CHOP fellow, recounts his experience caring for a cancer patient and the many firsts it brought to the both of them.

CHOP has been at the forefront of developing cell therapy to treat ALL. Some next steps include initiating clinical trials for AML and, ultimately, making this treatment work for solid tumors.

With the majority of Hodgkin lymphoma patients surviving their disease, the focus has turned to minimizing the long-term effects of treatment while maintaining excellent cure rates.

Using the case of a 14-year-old male diagnosed with osteosarcoma, we discuss the diagnosis and treatment of bone cancer with the goal of preserving limbs and functions.

As director, Magnusson leads a robust, multidisciplinary team that provides coordinated care and consultative services to patients with spina bifida and spinal cord defects.

With unparalleled level of expertise in prenatal diagnosis of spine deformities, our team is able to more accurately predict a child’s prognosis, explain the long-term impact, and discuss potential treatment options after birth.

Prenatal detection of congenital musculoskeletal and limb disorders helps us provide comprehensive expert care, from before birth into adulthood.